Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Jun 16, 2025

Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT

Author(s): Christine Curcio, PhD, Sheryl Stevenson Conferences|International SPECTRALIS Symposium – and Beyond From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer…

Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT

Jun 16, 2025

Cataract surgery may curb dementia, Alzheimer’s risk in those without anxiety, depression

By Justin Cooper Fact checked by Christine Klimanskis, ELS Key takeaways: Cataract surgery had a protective effect against overall dementia and Alzheimer’s, but not vascular dementia. There was no protection…

Cataract surgery may curb dementia, Alzheimer’s risk in those without anxiety, depression

Jun 16, 2025

Undiagnosed AMD prevalence in urban setting higher than national average

By Alex Young Fact checked by Eamon N. Dreisbach Key takeaways: A hospital in New York had a higher percentage of undiagnosed AMD compared with CDC reported values. Researchers hope…

Undiagnosed AMD prevalence in urban setting higher than national average

Jun 12, 2025

FDA nod for acoltremon: What its approval means for clinicians and patients

Author(s): Sheryl Stevenson Alcon’s announcement of the FDA approval for its acoltremon ophthalmic solution 0.003% (Tryptyr; formerly AR-15512) for the treatment of signs and symptoms of dry eye disease (DED)1,2 brings…

FDA nod for acoltremon: What its approval means for clinicians and patients

Jun 10, 2025

Press Release PAO Action Week

Press Release   Hello, The Macular Degeneration Association is one of the 1,200+ patient advocacy organizations (PAOs) in the United States working to support patients and caregivers. However, many people…

Press Release PAO Action Week

Jun 10, 2025

Home OCT a ‘safety net’ for reducing treatment burden in wet AMD

ByAnthony DeFino Fact checked byChristine Klimanskis, ELS Key takeaways: Home OCT may help patients achieve extended dosing intervals through consistent fluid evaluation. Scans are reviewed by AI through a cloud-based…

Home OCT a ‘safety net’ for reducing treatment burden in wet AMD

Jun 2, 2025

Stop Smoking Now to Protect Your Vision, Experts Warn

Edited by Shrabasti Bhattacharya TOPLINE: Current smokers faced up to 12-fold higher risk for age-related macular degeneration, a threefold higher risk for primary open-angle glaucoma, and a fourfold higher risk…

Stop Smoking Now to Protect Your Vision, Experts Warn

May 27, 2025

Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap

Author(s): Emily Kaiser Maharjan Key Takeaways Aldeyra’s phase 3 trial of reproxalap showed statistical superiority in reducing ocular discomfort compared to the vehicle, supporting NDA resubmission. The unique chamber trial…

Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap

May 26, 2025

Remember and Honor Our Fallen Heroes

“Their sacrifice was the ultimate act of love for their country. May we always remember them.” — Unknown

Remember and Honor Our Fallen Heroes

May 16, 2025

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

Exafield US, a healthcare market research company based in the USA, is conducting a study on visual impairments and would love to hear your opinions! We are seeking English-speaking individuals…

PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS

May 15, 2025

Living with GA: How patients in the US and Western Europe cope

Living with GA: How patients in the US and Western Europe cope Author(s): Lynda Charters Key Takeaways Geographic atrophy significantly impacts patients’ daily activities, independence, and mental health, necessitating coping…

Living with GA: How patients in the US and Western Europe cope

May 15, 2025

The eSight GO

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association When we were at our recent in-person seminar in Denver, we had the opportunity to have a representative…

The eSight GO

May 15, 2025

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association Photobiomodulation (PBM) is a new treatment that was recently approved (November 2024) by the United States Food &…

Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD

May 15, 2025

Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision

by Julie Poteet, OD, MS, CNS, FOWNS If you’re living with macular degeneration, you’ve likely heard about vitamins, antioxidants, and eating leafy greens to protect your eyes. But did you…

Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision

May 12, 2025

Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

May 11, 2025, By Sydney M Crago Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation…

Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD

May 11, 2025

Happy Mother’s Day

Wishing all the moms a wonderful day.

Happy Mother’s Day

May 2, 2025

“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”

By: Tatjana Josifova a,*, Katarzyna Konieczka b,c, Andreas Sch€otzau d, Josef Flammer b a Eye Clinic Orasis, Department for Medical and Surgical Retina, Reinach, Switzerland b Department of Ophthalmology, University…

“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”

Apr 22, 2025

A Young Man with the Heart of Gold- Running for Rita- Update

                    Running for Rita update Maxim finished the Half Marathon in 1 hour and 49 minutes. “Race day was amazing—such a…

A Young Man with the Heart of Gold- Running for Rita- Update

Apr 22, 2025

Treating dry eye disease may reduce migraine severity

By: Moira Mahoney Fact checked by: Christine Klimanskis, ELS Key takeaways: Treatment with ocular lubricants reduced Headache Impact Test scores in adults with migraine and dry eye disease. No significant…

Treating dry eye disease may reduce migraine severity

Apr 17, 2025

One Day Only- Matters of Vision! 2025 Denver-Aurora, CO

Matters of Vision! 2025 Denver-Aurora, CO. The Macular Degeneration Association will host a Free educational program on Saturday, May 10th. Registration required- Call (855) 962-2852 to reserve your seat(s)- Limited…

One Day Only- Matters of Vision! 2025 Denver-Aurora, CO

Apr 17, 2025

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy

Author(s): Martin David Harp Key Takeaways Vantage Biosciences has begun a phase 2 trial for VX-01, targeting moderate to severe NPDR without CI-DME. The study is double masked, randomized, placebo…

Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy

Apr 6, 2025

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

This is interesting and important. The bottom line: If you are getting treated for wet AMD and stop going to follow-ups, you are proven not to do as well as…

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

Mar 31, 2025

The Aira App: On Demand Expert Assistance

With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your smartphone, they walk you through whatever task you’re struggling to…

The Aira App: On Demand Expert Assistance

Mar 26, 2025

Researchers develop eye drops that slow progressive vision loss in mice

March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, to administer to mice in the form of a drop…

Researchers develop eye drops that slow progressive vision loss in mice

Mar 24, 2025

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, 2025, at 12 PM EDT Duration: 1 hour Learn how…

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Mar 24, 2025

Retinal vein occlusion (RVO) patients to participate in a paid market research study

      Opinions Link Research is looking for retinal vein occlusion (RVO) patients to participate in a paid market research study, sharing their opinions on this condition and treatments taken…

Retinal vein occlusion (RVO) patients to participate in a paid market research study

Mar 24, 2025

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

March 20, 2025, By Jordana Joy, Associate Editor Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline in the severity of overall dry…

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

Mar 18, 2025

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

New Research Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain inChildren: A Randomized Double‑Blind Placebo‑Controlled Trial Karen A.  Hecht· Megha Marwah· Vincent Wood· Yasuhiro Nishida· Austin E. Bach· Jeffry…

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

Mar 18, 2025

Cigarette smoking linked to reduced choroidal vascularity

Author(s): Lynda Charters Key Takeaways Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI). Smoking increases oxidative stress, affecting vascular endothelium and reducing retinal…

Cigarette smoking linked to reduced choroidal vascularity

Mar 14, 2025

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

By Sarah Caesar | Fact-checked by Barbara Bekiesz | Published March 10, 2025 Industry Buzz “[It’s] important to consider gradually tapering patients onto these drugs. Slowly lowering blood sugar, rather than doing so rapidly, may help reduce…

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.